Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation

NCT04377750 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT04377750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04377750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation
Lead sponsor
Hadassah Medical Organization
Phase
Phase 4
Overall status
Unknown status
Start date
April 8, 2020
Completion date
May 8, 2021
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

covid19 pneumonia